Evidence map›Paper›PMID 31534716›Full record

ArticleClinical case reports2019

A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?

Uros Markovic, Valeria Calafiore, Enrica Martino, Rachele Giubbolini, Marina Silvia Parisi, Alessandra Romano, Vittorio Del Fabro, Francesco Di Raimondo, Concetta Conticello

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Uros MarkovicDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.ORCID https://orcid.org/0000-0003-0868-5676
Valeria CalafioreDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Enrica MartinoDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Rachele GiubboliniDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Marina Silvia ParisiDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Alessandra RomanoDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Vittorio Del FabroDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Francesco Di RaimondoDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.
Concetta ConticelloDivision of Hematology, AOU "Policlinico - Vittorio Emanuele" University of Catania Catania Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a minority of relapsed myeloma, patient's disease may spread into extramedullary sites, associated with high degrees of heterogeneity. The breadth of myeloma therapeutic armamentarium allows clinicians to manage its heterogeneous presentation, including intracranial relapses, with fair success resulting in a significant prolongation of survival.

Indexed as

bortezomibextramedullary diseasemultiple myelomarefractoriness

Identifiers

PMID31534716
PMCPMC6745395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.